99 related articles for article (PubMed ID: 24120782)
1. Re: Effect of age, tumor risk, and comorbidity on competing risks for survival in a u.s. Population-based cohort of men with prostate cancer.
Penson DF
J Urol; 2013 Nov; 190(5):1766-7. PubMed ID: 24120782
[No Abstract] [Full Text] [Related]
2. Re: use of advanced treatment technologies among men at low risk of dying from prostate cancer.
See WA
Eur Urol; 2014 Jan; 65(1):250. PubMed ID: 24289855
[No Abstract] [Full Text] [Related]
3. Use of advanced treatment technologies among men at low risk of dying from prostate cancer.
Sammon JD; Trinh QD; Menon M
BJU Int; 2014 Aug; 114(2):166-7. PubMed ID: 24180347
[No Abstract] [Full Text] [Related]
4. Validation of an Age-adjusted Prostate Cancer-Specific Comorbidity Index.
Froehner M; Koch R; Hübler M; Wirth MP
Eur Urol; 2016 May; 69(5):764-6. PubMed ID: 26558839
[TBL] [Abstract][Full Text] [Related]
5. Re: Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer.
Taneja SS
J Urol; 2013 Oct; 190(4):1247. PubMed ID: 24029311
[No Abstract] [Full Text] [Related]
6. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study.
Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887
[TBL] [Abstract][Full Text] [Related]
7. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
Ishiyama H; Teh BS; Blanco AI; Paulino AC; Mai WY; Caillouet J; Xu B; Butler EB
Int J Urol; 2013 Dec; 20(12):1178-83. PubMed ID: 23573867
[TBL] [Abstract][Full Text] [Related]
8. Radical Prostatectomy versus External Beam Radiotherapy for cT1-4N0M0 Prostate Cancer: Comparison of Patient Outcomes Including Mortality.
Taguchi S; Fukuhara H; Shiraishi K; Nakagawa K; Morikawa T; Kakutani S; Takeshima Y; Miyazaki H; Fujimura T; Nakagawa T; Kume H; Homma Y
PLoS One; 2015; 10(10):e0141123. PubMed ID: 26506569
[TBL] [Abstract][Full Text] [Related]
9. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
Sweat SD; Bergstralh EJ; Slezak J; Blute ML; Zincke H
J Urol; 2002 Aug; 168(2):525-9. PubMed ID: 12131302
[TBL] [Abstract][Full Text] [Related]
10. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
[TBL] [Abstract][Full Text] [Related]
11. Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria.
Gandaglia G; Karakiewicz PI; Briganti A; Trudeau V; Trinh QD; Kim SP; Montorsi F; Nguyen PL; Abdollah F; Sun M
Int J Urol; 2015 Jan; 22(1):89-95. PubMed ID: 25141965
[TBL] [Abstract][Full Text] [Related]
12. Re: urologists' use of intensity-modulated radiation therapy for prostate cancer.
Penson DF
J Urol; 2014 May; 191(5):1292. PubMed ID: 24745495
[No Abstract] [Full Text] [Related]
13. A competing risk analysis of cancer-specific mortality of initial treatment with radical prostatectomy versus radiation therapy in clinically localized high-risk prostate cancer.
Lee JY; Cho KS; Kwon JK; Jeh SU; Kang HW; Diaz RR; Ham WS; Koom WS; Keum KC; Choi YD
Ann Surg Oncol; 2014 Nov; 21(12):4026-33. PubMed ID: 24841351
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment on: poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Barry MJ
Eur Urol; 2008 Jul; 54(1):116-7. PubMed ID: 17996360
[No Abstract] [Full Text] [Related]
15. [Are we overtreating low risk prostate cancer?].
Vera Donoso CD
Actas Urol Esp; 2012 Jan; 36(1):66. PubMed ID: 21963052
[No Abstract] [Full Text] [Related]
16. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis.
Wallis CJD; Saskin R; Choo R; Herschorn S; Kodama RT; Satkunasivam R; Shah PS; Danjoux C; Nam RK
Eur Urol; 2016 Jul; 70(1):21-30. PubMed ID: 26700655
[TBL] [Abstract][Full Text] [Related]
17. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
Jeldres C; Suardi N; Walz J; Saad F; Hutterer GC; Bhojani N; Shariat SF; Perrotte P; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol; 2008 Jul; 54(1):107-16. PubMed ID: 17996358
[TBL] [Abstract][Full Text] [Related]
18. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer.
Huang J; Kestin LL; Ye H; Wallace M; Martinez AA; Vicini FA
Radiother Oncol; 2011 Jan; 98(1):81-6. PubMed ID: 20951450
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses.
Koo KC; Cho JS; Bang WJ; Lee SH; Cho SY; Kim SI; Kim SJ; Rha KH; Hong SJ; Chung BH
Cancer Res Treat; 2018 Jan; 50(1):129-137. PubMed ID: 28279064
[TBL] [Abstract][Full Text] [Related]
20. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
